Showing
25 changed files
with
1626 additions
and
0 deletions
results/Dendogram_2clusters.png
0 → 100644

55 KB
results/Dendogram_3clusters.png
0 → 100644

55.2 KB
results/Dendogram_4clusters.png
0 → 100644

55.4 KB
results/Dendogram_ward.png
0 → 100644

27.8 KB
1 | +#Cluster: 1 | ||
2 | +1_s 1 | ||
3 | +3_s 3 | ||
4 | +5_s 5 | ||
5 | +6_s 6 | ||
6 | +7_s 7 | ||
7 | +8_s 8 | ||
8 | +10_s 10 | ||
9 | +12_s 12 | ||
10 | +13_s 13 | ||
11 | +14_s 14 | ||
12 | +16_s 16 | ||
13 | +17_s 17 | ||
14 | +18_s 18 | ||
15 | +20_s 20 | ||
16 | +22_s 22 | ||
17 | +23_s 23 | ||
18 | +24_s 24 | ||
19 | +25_s 25 | ||
20 | +28_s 28 | ||
21 | +29_s 29 | ||
22 | +31_s 31 | ||
23 | +33_s 33 | ||
24 | +34_s 34 | ||
25 | +37_s 37 | ||
26 | +38_s 38 | ||
27 | +42_s 42 | ||
28 | +43_s 43 | ||
29 | +44_s 44 | ||
30 | +47_s 47 | ||
31 | +48_s 48 | ||
32 | +49_s 49 | ||
33 | +54_s 54 | ||
34 | +55_s 55 | ||
35 | +58_s 58 | ||
36 | +59_s 59 | ||
37 | +64_s 64 | ||
38 | +65_s 65 | ||
39 | +66_s 66 | ||
40 | +67_s 67 | ||
41 | +69_s 69 | ||
42 | +70_s 70 | ||
43 | +71_s 71 | ||
44 | +72_s 72 | ||
45 | +74_s 74 | ||
46 | +75_s 75 | ||
47 | +79_s 79 | ||
48 | +80_s 80 | ||
49 | +81_s 81 | ||
50 | +82_s 82 | ||
51 | +83_s 83 | ||
52 | +84_s 84 | ||
53 | +86_s 86 | ||
54 | +87_s 87 | ||
55 | +88_s 88 | ||
56 | +89_s 89 | ||
57 | +90_s 90 | ||
58 | +91_s 91 | ||
59 | +92_s 92 | ||
60 | +93_s 93 | ||
61 | +94_s 94 | ||
62 | +98_s 98 | ||
63 | +100_s 100 | ||
64 | +101_s 101 | ||
65 | +102_s 102 | ||
66 | +104_s 104 | ||
67 | +106_s 106 | ||
68 | +109_s 109 | ||
69 | +110_s 110 | ||
70 | +112_s 112 | ||
71 | +115_s 115 | ||
72 | +117_s 117 | ||
73 | +118_s 118 | ||
74 | +120_s 120 | ||
75 | +123_s 123 | ||
76 | +124_s 124 | ||
77 | +127_s 126 | ||
78 | +128_s 127 | ||
79 | +130_s 129 | ||
80 | +132_s 131 | ||
81 | +136_s 135 | ||
82 | +137_s 136 | ||
83 | +138_s 137 | ||
84 | +141_s 140 | ||
85 | +142_s 141 | ||
86 | +144_s 143 | ||
87 | +146_s 145 | ||
88 | +147_s 146 | ||
89 | +148_s 147 | ||
90 | +149_s 148 | ||
91 | +150_s 149 | ||
92 | +156_s 155 | ||
93 | +159_s 158 | ||
94 | +161_s 160 | ||
95 | +162_s 161 | ||
96 | +163_s 162 | ||
97 | +164_s 163 | ||
98 | +165_s 164 | ||
99 | +166_s 165 | ||
100 | +169_s 168 | ||
101 | +171_s 169 | ||
102 | +174_s 172 | ||
103 | +177_s 175 | ||
104 | +179_s 177 | ||
105 | +182_s 180 | ||
106 | +184_s 182 | ||
107 | +186_s 184 | ||
108 | +188_s 186 | ||
109 | +189_s 187 | ||
110 | +190_s 188 | ||
111 | +192_s 190 | ||
112 | +195_s 193 | ||
113 | +196_s 194 | ||
114 | +197_s 195 | ||
115 | +198_s 196 | ||
116 | +199_s 197 | ||
117 | +203_s 201 | ||
118 | +204_s 202 | ||
119 | +205_s 203 | ||
120 | +208_s 206 | ||
121 | +210_s 208 | ||
122 | +214_s 212 | ||
123 | +215_s 213 | ||
124 | +216_s 214 | ||
125 | +217_s 215 | ||
126 | +219_s 217 | ||
127 | +220_s 218 | ||
128 | +221_s 219 | ||
129 | +222_s 220 | ||
130 | +223_s 221 | ||
131 | +225_s 223 | ||
132 | +226_s 224 | ||
133 | +227_s 225 | ||
134 | +229_s 227 | ||
135 | +230_s 228 | ||
136 | +233_s 231 | ||
137 | +234_s 232 | ||
138 | +236_s 234 | ||
139 | +237_s 235 | ||
140 | +238_s 236 | ||
141 | +239_s 237 | ||
142 | +240_s 238 | ||
143 | +241_s 239 | ||
144 | +242_s 240 | ||
145 | +243_s 241 | ||
146 | +244_s 242 | ||
147 | +245_s 243 | ||
148 | +246_s 244 | ||
149 | +247_s 245 | ||
150 | +248_s 246 | ||
151 | +250_s 248 | ||
152 | +251_s 249 | ||
153 | +253_s 250 | ||
154 | +254_s 251 | ||
155 | +255_s 252 | ||
156 | +256_s 253 | ||
157 | +260_s 257 | ||
158 | +262_s 259 | ||
159 | +264_s 261 | ||
160 | +265_s 262 | ||
161 | +268_s 265 | ||
162 | +269_s 266 | ||
163 | +272_s 269 | ||
164 | +273_s 270 | ||
165 | +275_s 272 | ||
166 | +278_s 275 | ||
167 | +279_s 276 | ||
168 | +280_s 277 | ||
169 | +281_s 278 | ||
170 | +284_s 281 | ||
171 | +286_s 283 | ||
172 | +287_s 284 | ||
173 | +289_s 286 | ||
174 | +290_s 287 | ||
175 | +291_s 288 | ||
176 | +293_s 289 | ||
177 | +295_s 291 | ||
178 | +297_s 293 | ||
179 | +298_s 294 | ||
180 | +299_s 295 | ||
181 | +300_s 296 | ||
182 | +301_s 297 | ||
183 | +302_s 298 | ||
184 | +303_s 299 | ||
185 | +305_s 301 | ||
186 | +307_s 303 | ||
187 | +308_s 304 | ||
188 | +310_s 306 | ||
189 | +313_s 309 | ||
190 | +314_s 310 | ||
191 | +315_s 311 | ||
192 | +316_s 312 | ||
193 | +317_s 313 | ||
194 | +318_s 314 | ||
195 | +320_s 316 | ||
196 | +322_s 318 | ||
197 | +325_s 321 | ||
198 | +326_s 322 | ||
199 | +328_s 324 | ||
200 | +330_s 326 | ||
201 | +332_s 328 | ||
202 | +333_s 329 | ||
203 | +335_s 331 | ||
204 | +336_s 332 | ||
205 | +340_s 336 | ||
206 | +343_s 339 | ||
207 | +345_s 341 | ||
208 | +347_s 343 | ||
209 | +348_s 344 | ||
210 | +349_s 345 | ||
211 | +350_s 346 | ||
212 | +352_s 348 | ||
213 | +353_s 349 | ||
214 | +354_s 350 | ||
215 | +355_s 351 | ||
216 | +356_s 352 | ||
217 | +357_s 353 | ||
218 | +360_s 356 | ||
219 | +361_s 357 | ||
220 | +362_s 358 | ||
221 | +363_s 359 | ||
222 | +364_s 360 | ||
223 | +365_s 361 | ||
224 | +366_s 362 | ||
225 | +367_s 363 | ||
226 | +368_s 364 | ||
227 | +371_s 367 | ||
228 | +372_s 368 | ||
229 | +374_s 370 | ||
230 | +375_s 371 | ||
231 | +376_s 372 | ||
232 | +377_s 373 | ||
233 | +378_s 374 | ||
234 | +379_s 375 | ||
235 | +380_s 376 | ||
236 | +383_s 379 | ||
237 | +384_s 380 | ||
238 | +387_s 383 | ||
239 | +388_s 384 | ||
240 | +390_s 386 | ||
241 | +391_s 387 | ||
242 | +392_s 388 | ||
243 | +398_s 394 | ||
244 | +399_s 395 | ||
245 | +401_s 397 | ||
246 | +402_s 398 | ||
247 | +403_s 399 | ||
248 | +407_s 403 | ||
249 | +408_s 404 | ||
250 | +409_s 405 | ||
251 | +411_s 407 | ||
252 | +413_s 409 | ||
253 | +414_s 410 | ||
254 | +415_s 411 | ||
255 | +416_s 412 | ||
256 | +418_s 414 | ||
257 | +419_s 415 | ||
258 | +420_s 416 | ||
259 | +421_s 417 | ||
260 | +424_s 420 | ||
261 | +428_s 424 | ||
262 | +429_s 425 | ||
263 | +431_s 427 | ||
264 | +433_s 429 | ||
265 | +437_s 433 | ||
266 | +438_s 434 | ||
267 | +440_s 436 | ||
268 | +442_s 438 | ||
269 | +443_s 439 | ||
270 | +444_s 440 | ||
271 | +445_s 441 | ||
272 | +446_s 442 | ||
273 | +447_s 443 | ||
274 | +448_s 444 | ||
275 | +450_s 446 | ||
276 | +451_s 447 | ||
277 | +452_s 448 | ||
278 | +453_s 449 | ||
279 | +#Cluster: 2 | ||
280 | +2_s 2 | ||
281 | +4_s 4 | ||
282 | +9_s 9 | ||
283 | +11_s 11 | ||
284 | +15_s 15 | ||
285 | +19_s 19 | ||
286 | +21_s 21 | ||
287 | +26_s 26 | ||
288 | +27_s 27 | ||
289 | +30_s 30 | ||
290 | +32_s 32 | ||
291 | +35_s 35 | ||
292 | +36_s 36 | ||
293 | +39_s 39 | ||
294 | +40_s 40 | ||
295 | +41_s 41 | ||
296 | +45_s 45 | ||
297 | +46_s 46 | ||
298 | +50_s 50 | ||
299 | +51_s 51 | ||
300 | +52_s 52 | ||
301 | +53_s 53 | ||
302 | +56_s 56 | ||
303 | +57_s 57 | ||
304 | +60_s 60 | ||
305 | +61_s 61 | ||
306 | +62_s 62 | ||
307 | +63_s 63 | ||
308 | +68_s 68 | ||
309 | +73_s 73 | ||
310 | +76_s 76 | ||
311 | +77_s 77 | ||
312 | +78_s 78 | ||
313 | +85_s 85 | ||
314 | +95_s 95 | ||
315 | +96_s 96 | ||
316 | +97_s 97 | ||
317 | +99_s 99 | ||
318 | +103_s 103 | ||
319 | +105_s 105 | ||
320 | +107_s 107 | ||
321 | +108_s 108 | ||
322 | +111_s 111 | ||
323 | +113_s 113 | ||
324 | +114_s 114 | ||
325 | +116_s 116 | ||
326 | +119_s 119 | ||
327 | +121_s 121 | ||
328 | +122_s 122 | ||
329 | +125_s 125 | ||
330 | +129_s 128 | ||
331 | +131_s 130 | ||
332 | +133_s 132 | ||
333 | +134_s 133 | ||
334 | +135_s 134 | ||
335 | +139_s 138 | ||
336 | +140_s 139 | ||
337 | +143_s 142 | ||
338 | +145_s 144 | ||
339 | +151_s 150 | ||
340 | +152_s 151 | ||
341 | +153_s 152 | ||
342 | +154_s 153 | ||
343 | +155_s 154 | ||
344 | +157_s 156 | ||
345 | +158_s 157 | ||
346 | +160_s 159 | ||
347 | +167_s 166 | ||
348 | +168_s 167 | ||
349 | +172_s 170 | ||
350 | +173_s 171 | ||
351 | +175_s 173 | ||
352 | +176_s 174 | ||
353 | +178_s 176 | ||
354 | +180_s 178 | ||
355 | +181_s 179 | ||
356 | +183_s 181 | ||
357 | +185_s 183 | ||
358 | +187_s 185 | ||
359 | +191_s 189 | ||
360 | +193_s 191 | ||
361 | +194_s 192 | ||
362 | +200_s 198 | ||
363 | +201_s 199 | ||
364 | +202_s 200 | ||
365 | +206_s 204 | ||
366 | +207_s 205 | ||
367 | +209_s 207 | ||
368 | +211_s 209 | ||
369 | +212_s 210 | ||
370 | +213_s 211 | ||
371 | +218_s 216 | ||
372 | +224_s 222 | ||
373 | +228_s 226 | ||
374 | +231_s 229 | ||
375 | +232_s 230 | ||
376 | +235_s 233 | ||
377 | +249_s 247 | ||
378 | +257_s 254 | ||
379 | +258_s 255 | ||
380 | +259_s 256 | ||
381 | +261_s 258 | ||
382 | +263_s 260 | ||
383 | +266_s 263 | ||
384 | +267_s 264 | ||
385 | +270_s 267 | ||
386 | +271_s 268 | ||
387 | +274_s 271 | ||
388 | +276_s 273 | ||
389 | +277_s 274 | ||
390 | +282_s 279 | ||
391 | +283_s 280 | ||
392 | +285_s 282 | ||
393 | +288_s 285 | ||
394 | +294_s 290 | ||
395 | +296_s 292 | ||
396 | +304_s 300 | ||
397 | +306_s 302 | ||
398 | +309_s 305 | ||
399 | +311_s 307 | ||
400 | +312_s 308 | ||
401 | +319_s 315 | ||
402 | +321_s 317 | ||
403 | +323_s 319 | ||
404 | +324_s 320 | ||
405 | +327_s 323 | ||
406 | +329_s 325 | ||
407 | +331_s 327 | ||
408 | +334_s 330 | ||
409 | +337_s 333 | ||
410 | +338_s 334 | ||
411 | +339_s 335 | ||
412 | +341_s 337 | ||
413 | +342_s 338 | ||
414 | +344_s 340 | ||
415 | +346_s 342 | ||
416 | +351_s 347 | ||
417 | +358_s 354 | ||
418 | +359_s 355 | ||
419 | +369_s 365 | ||
420 | +370_s 366 | ||
421 | +373_s 369 | ||
422 | +381_s 377 | ||
423 | +382_s 378 | ||
424 | +385_s 381 | ||
425 | +386_s 382 | ||
426 | +389_s 385 | ||
427 | +393_s 389 | ||
428 | +394_s 390 | ||
429 | +395_s 391 | ||
430 | +396_s 392 | ||
431 | +397_s 393 | ||
432 | +400_s 396 | ||
433 | +404_s 400 | ||
434 | +405_s 401 | ||
435 | +406_s 402 | ||
436 | +410_s 406 | ||
437 | +412_s 408 | ||
438 | +417_s 413 | ||
439 | +422_s 418 | ||
440 | +423_s 419 | ||
441 | +425_s 421 | ||
442 | +426_s 422 | ||
443 | +427_s 423 | ||
444 | +430_s 426 | ||
445 | +432_s 428 | ||
446 | +434_s 430 | ||
447 | +435_s 431 | ||
448 | +436_s 432 | ||
449 | +439_s 435 | ||
450 | +441_s 437 | ||
451 | +449_s 445 | ||
452 | +454_s 450 | ||
453 | +455_s 451 | ||
... | \ No newline at end of file | ... | \ No newline at end of file |
results/Partition_2/cluster1.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_2/cluster1_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_2/cluster2.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_2/cluster2_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
1 | +#Cluster: 1 | ||
2 | +1_s 1 | ||
3 | +3_s 3 | ||
4 | +5_s 5 | ||
5 | +6_s 6 | ||
6 | +7_s 7 | ||
7 | +8_s 8 | ||
8 | +10_s 10 | ||
9 | +12_s 12 | ||
10 | +13_s 13 | ||
11 | +14_s 14 | ||
12 | +16_s 16 | ||
13 | +17_s 17 | ||
14 | +18_s 18 | ||
15 | +20_s 20 | ||
16 | +22_s 22 | ||
17 | +23_s 23 | ||
18 | +24_s 24 | ||
19 | +25_s 25 | ||
20 | +28_s 28 | ||
21 | +29_s 29 | ||
22 | +31_s 31 | ||
23 | +33_s 33 | ||
24 | +34_s 34 | ||
25 | +37_s 37 | ||
26 | +38_s 38 | ||
27 | +42_s 42 | ||
28 | +43_s 43 | ||
29 | +44_s 44 | ||
30 | +47_s 47 | ||
31 | +48_s 48 | ||
32 | +49_s 49 | ||
33 | +54_s 54 | ||
34 | +55_s 55 | ||
35 | +58_s 58 | ||
36 | +59_s 59 | ||
37 | +64_s 64 | ||
38 | +65_s 65 | ||
39 | +66_s 66 | ||
40 | +67_s 67 | ||
41 | +69_s 69 | ||
42 | +70_s 70 | ||
43 | +71_s 71 | ||
44 | +72_s 72 | ||
45 | +74_s 74 | ||
46 | +75_s 75 | ||
47 | +79_s 79 | ||
48 | +80_s 80 | ||
49 | +81_s 81 | ||
50 | +82_s 82 | ||
51 | +83_s 83 | ||
52 | +84_s 84 | ||
53 | +86_s 86 | ||
54 | +87_s 87 | ||
55 | +88_s 88 | ||
56 | +89_s 89 | ||
57 | +90_s 90 | ||
58 | +91_s 91 | ||
59 | +92_s 92 | ||
60 | +93_s 93 | ||
61 | +94_s 94 | ||
62 | +98_s 98 | ||
63 | +100_s 100 | ||
64 | +101_s 101 | ||
65 | +102_s 102 | ||
66 | +104_s 104 | ||
67 | +106_s 106 | ||
68 | +109_s 109 | ||
69 | +110_s 110 | ||
70 | +112_s 112 | ||
71 | +115_s 115 | ||
72 | +117_s 117 | ||
73 | +118_s 118 | ||
74 | +120_s 120 | ||
75 | +123_s 123 | ||
76 | +124_s 124 | ||
77 | +127_s 126 | ||
78 | +128_s 127 | ||
79 | +130_s 129 | ||
80 | +132_s 131 | ||
81 | +136_s 135 | ||
82 | +137_s 136 | ||
83 | +138_s 137 | ||
84 | +141_s 140 | ||
85 | +142_s 141 | ||
86 | +144_s 143 | ||
87 | +146_s 145 | ||
88 | +147_s 146 | ||
89 | +148_s 147 | ||
90 | +149_s 148 | ||
91 | +150_s 149 | ||
92 | +156_s 155 | ||
93 | +159_s 158 | ||
94 | +161_s 160 | ||
95 | +162_s 161 | ||
96 | +163_s 162 | ||
97 | +164_s 163 | ||
98 | +165_s 164 | ||
99 | +166_s 165 | ||
100 | +169_s 168 | ||
101 | +171_s 169 | ||
102 | +174_s 172 | ||
103 | +177_s 175 | ||
104 | +179_s 177 | ||
105 | +182_s 180 | ||
106 | +184_s 182 | ||
107 | +186_s 184 | ||
108 | +188_s 186 | ||
109 | +189_s 187 | ||
110 | +190_s 188 | ||
111 | +192_s 190 | ||
112 | +195_s 193 | ||
113 | +196_s 194 | ||
114 | +197_s 195 | ||
115 | +198_s 196 | ||
116 | +199_s 197 | ||
117 | +203_s 201 | ||
118 | +204_s 202 | ||
119 | +205_s 203 | ||
120 | +208_s 206 | ||
121 | +210_s 208 | ||
122 | +214_s 212 | ||
123 | +215_s 213 | ||
124 | +216_s 214 | ||
125 | +217_s 215 | ||
126 | +219_s 217 | ||
127 | +220_s 218 | ||
128 | +221_s 219 | ||
129 | +222_s 220 | ||
130 | +223_s 221 | ||
131 | +225_s 223 | ||
132 | +226_s 224 | ||
133 | +227_s 225 | ||
134 | +229_s 227 | ||
135 | +230_s 228 | ||
136 | +233_s 231 | ||
137 | +234_s 232 | ||
138 | +236_s 234 | ||
139 | +237_s 235 | ||
140 | +238_s 236 | ||
141 | +239_s 237 | ||
142 | +240_s 238 | ||
143 | +241_s 239 | ||
144 | +242_s 240 | ||
145 | +243_s 241 | ||
146 | +244_s 242 | ||
147 | +245_s 243 | ||
148 | +246_s 244 | ||
149 | +247_s 245 | ||
150 | +248_s 246 | ||
151 | +250_s 248 | ||
152 | +251_s 249 | ||
153 | +253_s 250 | ||
154 | +254_s 251 | ||
155 | +255_s 252 | ||
156 | +256_s 253 | ||
157 | +260_s 257 | ||
158 | +262_s 259 | ||
159 | +264_s 261 | ||
160 | +265_s 262 | ||
161 | +268_s 265 | ||
162 | +269_s 266 | ||
163 | +272_s 269 | ||
164 | +273_s 270 | ||
165 | +275_s 272 | ||
166 | +278_s 275 | ||
167 | +279_s 276 | ||
168 | +280_s 277 | ||
169 | +281_s 278 | ||
170 | +284_s 281 | ||
171 | +286_s 283 | ||
172 | +287_s 284 | ||
173 | +289_s 286 | ||
174 | +290_s 287 | ||
175 | +291_s 288 | ||
176 | +293_s 289 | ||
177 | +295_s 291 | ||
178 | +297_s 293 | ||
179 | +298_s 294 | ||
180 | +299_s 295 | ||
181 | +300_s 296 | ||
182 | +301_s 297 | ||
183 | +302_s 298 | ||
184 | +303_s 299 | ||
185 | +305_s 301 | ||
186 | +307_s 303 | ||
187 | +308_s 304 | ||
188 | +310_s 306 | ||
189 | +313_s 309 | ||
190 | +314_s 310 | ||
191 | +315_s 311 | ||
192 | +316_s 312 | ||
193 | +317_s 313 | ||
194 | +318_s 314 | ||
195 | +320_s 316 | ||
196 | +322_s 318 | ||
197 | +325_s 321 | ||
198 | +326_s 322 | ||
199 | +328_s 324 | ||
200 | +330_s 326 | ||
201 | +332_s 328 | ||
202 | +333_s 329 | ||
203 | +335_s 331 | ||
204 | +336_s 332 | ||
205 | +340_s 336 | ||
206 | +343_s 339 | ||
207 | +345_s 341 | ||
208 | +347_s 343 | ||
209 | +348_s 344 | ||
210 | +349_s 345 | ||
211 | +350_s 346 | ||
212 | +352_s 348 | ||
213 | +353_s 349 | ||
214 | +354_s 350 | ||
215 | +355_s 351 | ||
216 | +356_s 352 | ||
217 | +357_s 353 | ||
218 | +360_s 356 | ||
219 | +361_s 357 | ||
220 | +362_s 358 | ||
221 | +363_s 359 | ||
222 | +364_s 360 | ||
223 | +365_s 361 | ||
224 | +366_s 362 | ||
225 | +367_s 363 | ||
226 | +368_s 364 | ||
227 | +371_s 367 | ||
228 | +372_s 368 | ||
229 | +374_s 370 | ||
230 | +375_s 371 | ||
231 | +376_s 372 | ||
232 | +377_s 373 | ||
233 | +378_s 374 | ||
234 | +379_s 375 | ||
235 | +380_s 376 | ||
236 | +383_s 379 | ||
237 | +384_s 380 | ||
238 | +387_s 383 | ||
239 | +388_s 384 | ||
240 | +390_s 386 | ||
241 | +391_s 387 | ||
242 | +392_s 388 | ||
243 | +398_s 394 | ||
244 | +399_s 395 | ||
245 | +401_s 397 | ||
246 | +402_s 398 | ||
247 | +403_s 399 | ||
248 | +407_s 403 | ||
249 | +408_s 404 | ||
250 | +409_s 405 | ||
251 | +411_s 407 | ||
252 | +413_s 409 | ||
253 | +414_s 410 | ||
254 | +415_s 411 | ||
255 | +416_s 412 | ||
256 | +418_s 414 | ||
257 | +419_s 415 | ||
258 | +420_s 416 | ||
259 | +421_s 417 | ||
260 | +424_s 420 | ||
261 | +428_s 424 | ||
262 | +429_s 425 | ||
263 | +431_s 427 | ||
264 | +433_s 429 | ||
265 | +437_s 433 | ||
266 | +438_s 434 | ||
267 | +440_s 436 | ||
268 | +442_s 438 | ||
269 | +443_s 439 | ||
270 | +444_s 440 | ||
271 | +445_s 441 | ||
272 | +446_s 442 | ||
273 | +447_s 443 | ||
274 | +448_s 444 | ||
275 | +450_s 446 | ||
276 | +451_s 447 | ||
277 | +452_s 448 | ||
278 | +453_s 449 | ||
279 | +#Cluster: 2 | ||
280 | +9_s 9 | ||
281 | +19_s 19 | ||
282 | +21_s 21 | ||
283 | +26_s 26 | ||
284 | +32_s 32 | ||
285 | +39_s 39 | ||
286 | +52_s 52 | ||
287 | +73_s 73 | ||
288 | +77_s 77 | ||
289 | +95_s 95 | ||
290 | +107_s 107 | ||
291 | +113_s 113 | ||
292 | +125_s 125 | ||
293 | +129_s 128 | ||
294 | +131_s 130 | ||
295 | +145_s 144 | ||
296 | +153_s 152 | ||
297 | +158_s 157 | ||
298 | +172_s 170 | ||
299 | +175_s 173 | ||
300 | +180_s 178 | ||
301 | +200_s 198 | ||
302 | +202_s 200 | ||
303 | +207_s 205 | ||
304 | +224_s 222 | ||
305 | +228_s 226 | ||
306 | +231_s 229 | ||
307 | +259_s 256 | ||
308 | +263_s 260 | ||
309 | +274_s 271 | ||
310 | +283_s 280 | ||
311 | +288_s 285 | ||
312 | +306_s 302 | ||
313 | +321_s 317 | ||
314 | +323_s 319 | ||
315 | +334_s 330 | ||
316 | +359_s 355 | ||
317 | +382_s 378 | ||
318 | +395_s 391 | ||
319 | +417_s 413 | ||
320 | +434_s 430 | ||
321 | +454_s 450 | ||
322 | +#Cluster: 3 | ||
323 | +2_s 2 | ||
324 | +4_s 4 | ||
325 | +11_s 11 | ||
326 | +15_s 15 | ||
327 | +27_s 27 | ||
328 | +30_s 30 | ||
329 | +35_s 35 | ||
330 | +36_s 36 | ||
331 | +40_s 40 | ||
332 | +41_s 41 | ||
333 | +45_s 45 | ||
334 | +46_s 46 | ||
335 | +50_s 50 | ||
336 | +51_s 51 | ||
337 | +53_s 53 | ||
338 | +56_s 56 | ||
339 | +57_s 57 | ||
340 | +60_s 60 | ||
341 | +61_s 61 | ||
342 | +62_s 62 | ||
343 | +63_s 63 | ||
344 | +68_s 68 | ||
345 | +76_s 76 | ||
346 | +78_s 78 | ||
347 | +85_s 85 | ||
348 | +96_s 96 | ||
349 | +97_s 97 | ||
350 | +99_s 99 | ||
351 | +103_s 103 | ||
352 | +105_s 105 | ||
353 | +108_s 108 | ||
354 | +111_s 111 | ||
355 | +114_s 114 | ||
356 | +116_s 116 | ||
357 | +119_s 119 | ||
358 | +121_s 121 | ||
359 | +122_s 122 | ||
360 | +133_s 132 | ||
361 | +134_s 133 | ||
362 | +135_s 134 | ||
363 | +139_s 138 | ||
364 | +140_s 139 | ||
365 | +143_s 142 | ||
366 | +151_s 150 | ||
367 | +152_s 151 | ||
368 | +154_s 153 | ||
369 | +155_s 154 | ||
370 | +157_s 156 | ||
371 | +160_s 159 | ||
372 | +167_s 166 | ||
373 | +168_s 167 | ||
374 | +173_s 171 | ||
375 | +176_s 174 | ||
376 | +178_s 176 | ||
377 | +181_s 179 | ||
378 | +183_s 181 | ||
379 | +185_s 183 | ||
380 | +187_s 185 | ||
381 | +191_s 189 | ||
382 | +193_s 191 | ||
383 | +194_s 192 | ||
384 | +201_s 199 | ||
385 | +206_s 204 | ||
386 | +209_s 207 | ||
387 | +211_s 209 | ||
388 | +212_s 210 | ||
389 | +213_s 211 | ||
390 | +218_s 216 | ||
391 | +232_s 230 | ||
392 | +235_s 233 | ||
393 | +249_s 247 | ||
394 | +257_s 254 | ||
395 | +258_s 255 | ||
396 | +261_s 258 | ||
397 | +266_s 263 | ||
398 | +267_s 264 | ||
399 | +270_s 267 | ||
400 | +271_s 268 | ||
401 | +276_s 273 | ||
402 | +277_s 274 | ||
403 | +282_s 279 | ||
404 | +285_s 282 | ||
405 | +294_s 290 | ||
406 | +296_s 292 | ||
407 | +304_s 300 | ||
408 | +309_s 305 | ||
409 | +311_s 307 | ||
410 | +312_s 308 | ||
411 | +319_s 315 | ||
412 | +324_s 320 | ||
413 | +327_s 323 | ||
414 | +329_s 325 | ||
415 | +331_s 327 | ||
416 | +337_s 333 | ||
417 | +338_s 334 | ||
418 | +339_s 335 | ||
419 | +341_s 337 | ||
420 | +342_s 338 | ||
421 | +344_s 340 | ||
422 | +346_s 342 | ||
423 | +351_s 347 | ||
424 | +358_s 354 | ||
425 | +369_s 365 | ||
426 | +370_s 366 | ||
427 | +373_s 369 | ||
428 | +381_s 377 | ||
429 | +385_s 381 | ||
430 | +386_s 382 | ||
431 | +389_s 385 | ||
432 | +393_s 389 | ||
433 | +394_s 390 | ||
434 | +396_s 392 | ||
435 | +397_s 393 | ||
436 | +400_s 396 | ||
437 | +404_s 400 | ||
438 | +405_s 401 | ||
439 | +406_s 402 | ||
440 | +410_s 406 | ||
441 | +412_s 408 | ||
442 | +422_s 418 | ||
443 | +423_s 419 | ||
444 | +425_s 421 | ||
445 | +426_s 422 | ||
446 | +427_s 423 | ||
447 | +430_s 426 | ||
448 | +432_s 428 | ||
449 | +435_s 431 | ||
450 | +436_s 432 | ||
451 | +439_s 435 | ||
452 | +441_s 437 | ||
453 | +449_s 445 | ||
454 | +455_s 451 | ||
... | \ No newline at end of file | ... | \ No newline at end of file |
results/Partition_3/cluster1.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_3/cluster1_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_3/cluster2.txt
0 → 100644
1 | +Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema | ||
2 | +Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts | ||
3 | +Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis | ||
4 | +Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis | ||
5 | +The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis | ||
6 | +Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis | ||
7 | +Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs | ||
8 | +Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis | ||
9 | +Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis | ||
10 | +Amplification of TGFb Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis | ||
11 | +Macrophage Bone Morphogenic Protein Receptor 2 (BMPR2) depletion in Idiopathic Pulmonary Fibrosis (IPF) and Group III Pulmonary Hypertension | ||
12 | +Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion | ||
13 | +Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice | ||
14 | +Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis | ||
15 | +miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-b Receptor II | ||
16 | +Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2 | ||
17 | +Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-b1 Signal Pathway | ||
18 | +Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1 | ||
19 | +Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production | ||
20 | +Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen Production | ||
21 | +Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis | ||
22 | +Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2 | ||
23 | +Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model | ||
24 | +AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation | ||
25 | +Novel Mechanisms for the Antifibrotic Action of Nintedanib | ||
26 | +Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem | ||
27 | +Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia | ||
28 | +Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin avb6 Expression | ||
29 | +Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis | ||
30 | +The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis | ||
31 | +MAP3K19 Is a Novel Regulator of TGF-b Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis | ||
32 | +Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-b1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt | ||
33 | +Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts: Possible Implications in Idiopathic Pulmonary Fibrosis | ||
34 | +Regulation of 26S Proteasome Activity in Pulmonary Fibrosis | ||
35 | +Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis | ||
36 | +The Role of PPARs in Lung Fibrosis | ||
37 | +Lipoxin A4 Attenuates Constitutive and TGF-b1-Dependent Profibrotic Activity in Human Lung Myofibroblasts | ||
38 | +Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells | ||
39 | +Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics | ||
40 | +CXCL9 Regulates TGF-b1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells | ||
41 | +Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural Fibrosis | ||
42 | +Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-b and WNT7B in Human Lung Fibroblasts |
results/Partition_3/cluster2_tagged.txt
0 → 100644
1 | +<r>Regulation </r>of human lung fibroblast <g>C1q</g>-receptors by <g>transforming growth factor-beta</g> and <g>tumor necrosis factor-alpha</g> | ||
2 | +High levels of <g>IL-6</g> and <g>IL-8</g> characterize early-on <d>idiopathic pulmonary fibrosis</d> acute exacerbations | ||
3 | +Regulation of the effects of <g>TGF-beta 1</g> by activation of latent <g>TGF-beta 1</g> and differential <e>expression </e>of <g>TGF-beta receptors (T beta R-I and T beta R-II</g>) in <d>idiopathic pulmonary fibrosis</d> | ||
4 | +Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in <d>idiopathic pulmonary fibrosis</d> patients | ||
5 | +<g>miR-9-5p</g> suppresses pro-fibrogenic transformation of fibroblasts and prevents organ <d>fibrosis</d> by targeting <g>NOX4</g> and <g>TGFBR2</g> | ||
6 | +Profibrotic role of <g>WNT10A</g> via <g>TGF-b</g> signaling in <d>idiopathic pulmonary fibrosis</d> | ||
7 | +Microarray profiling reveals <u>suppressed </u>interferon stimulated gene program in fibroblasts from scleroderma-associated <d>interstitial lung disease</d> | ||
8 | +<g>IL-4</g> polymorphisms, HRCT score and lung tissue markers in <d>idiopathic pulmonary fibrosis</d> | ||
9 | +Herpes <d>virus infection</d> is associated with vascular remodeling and <d>pulmonary hypertension</d> in <d>idiopathic pulmonary fibrosis</d> | ||
10 | +Microencapsulation of lefty-secreting engineered cells for <d>pulmonary fibrosis</d> therapy in mice | ||
11 | +Targeting of <g>Discoidin Domain Receptor 2</g> (<g>DDR2</g>) Prevents Myofibroblast Activation and Neovessel Formation During <d>Pulmonary Fibrosis</d> | ||
12 | +Role of <g>protease-activated receptor-2</g> in <d>idiopathic pulmonary fibrosis</d> | ||
13 | +<g>Chop</g> | ||
14 | +<g>VCAM-1</g> is a <g>TGF-b1</g> inducible gene <v>upregulated </v>in <d>idiopathic pulmonary fibrosis</d> | ||
15 | +<u>Suppression </u>of <g>plasminogen activator inhibitor-1</g> by RNA interference attenuates <d>pulmonary fibrosis</d> | ||
16 | +<g>JAK2</g> mediates <d>lung fibrosis</d>, <d>pulmonary vascular remodelling</d> and <d>hypertension</d> in <d>idiopathic pulmonary fibrosis</d>: an experimental study | ||
17 | +Melatonin attenuates <g>TGFb1</g>-induced epithelial-mesenchymal transition in lung alveolar epithelial cells | ||
18 | +<r>Deregulation </r>of selective autophagy during aging and <d>pulmonary fibrosis</d>: the role of <g>TGFb1</g> | ||
19 | +<g>RhoA</g> signaling <r>modulates </r><g>cyclin D1</g> <e>expression </e>in human lung fibroblasts; implications for <d>idiopathic pulmonary fibrosis</d> | ||
20 | +Inhibitory effect of <g>receptor for advanced glycation end products</g> (<g>RAGE</g>) on the <g>TGF-b</g>-induced alveolar epithelial to mesenchymal transition | ||
21 | +<e>Effects </e>of the <d>tumor</d> suppressor <g>PTEN</g> on the pathogenesis of <d>idiopathic pulmonary fibrosis</d> in Chinese patients | ||
22 | +Triptolide suppresses paraquat induced <d>idiopathic pulmonary fibrosis</d> by inhibiting <g>TGFB1</g>-dependent epithelial mesenchymal transition | ||
23 | +<g>Endothelin-1</g> <v>induces </v>alveolar epithelial-mesenchymal transition through endothelin type A receptor-<v>mediated </v><e>production </e>of <g>TGF-beta1</g> | ||
24 | +<g>p63</g> - Key molecule in the early phase of <d>epithelial abnormality</d> in <d>idiopathic pulmonary fibrosis</d> | ||
25 | +The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in <d>idiopathic pulmonary fibrosis</d> | ||
26 | +<v>Upregulation </v>of <g>activin</g>-B and <g>follistatin</g> in <d>pulmonary fibrosis</d> - a translational study using human biopsies and a specific inhibitor in mouse <d>fibrosis</d> models | ||
27 | +<u>Inhibition </u>of the <g>KCa3.1</g> | ||
28 | +Current and novel drug therapies for <d>idiopathic pulmonary fibrosis</d> | ||
29 | +<g>Protease activated receptor-1</g> regulates macrophage-mediated cellular senescence: a risk for <d>idiopathic pulmonary fibrosis</d> | ||
30 | +Sphingolipids in <d>pulmonary fibrosis</d> | ||
31 | +Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts | ||
32 | +Pirfenidone for the treatment of <d>idiopathic pulmonary fibrosis</d> | ||
33 | +The anti-fibrotic effect of <u>inhibition </u>of <g>TGFb</g>-<g>ALK5</g> signalling in experimental <d>pulmonary fibrosis</d> in mice is attenuated in the presence of concurrent y-herpesvirus infection | ||
34 | +Angiotensin-<g>TGF-beta</g> 1 crosstalk in human <d>idiopathic pulmonary fibrosis</d>: autocrine mechanisms in myofibroblasts and macrophages | ||
35 | +SNAI transcription factors mediate epithelial-mesenchymal transition in <d>lung fibrosis</d> | ||
36 | +<g>MiR-338</g>* suppresses fibrotic pathogenesis in <d>pulmonary fibrosis</d> through targeting <g>LPA1</g> | ||
37 | +BALF N-acetylglucosaminidase and <g>beta-galactosidase</g> activities in <d>idiopathic pulmonary fibrosis</d> | ||
38 | +<g>Th1</g>/Th2 cytokine gene polymorphisms in patients with <d>idiopathic pulmonary fibrosis</d> | ||
39 | +Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen <e>Production.</e> <g>TGF-b</g> <v>promotes </v>excessive collagen deposition in <d>fibrotic diseases</d> such as <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>) | ||
40 | +The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells | ||
41 | +<g>Transcription factor GATA-6</g> is <e>expressed </e>in quiescent myofibroblasts in <d>idiopathic pulmonary fibrosis</d> | ||
42 | +Epithelial-to-mesenchymal transition and its role in <g>EGFR</g>-mutant <d>lung adenocarcinoma</d> and <d>idiopathic pulmonary fibrosis</d> |
results/Partition_3/cluster3.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_3/cluster3_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
1 | +#Cluster: 1 | ||
2 | +3_s 3 | ||
3 | +17_s 17 | ||
4 | +33_s 33 | ||
5 | +42_s 42 | ||
6 | +43_s 43 | ||
7 | +59_s 59 | ||
8 | +66_s 66 | ||
9 | +82_s 82 | ||
10 | +84_s 84 | ||
11 | +100_s 100 | ||
12 | +123_s 123 | ||
13 | +124_s 124 | ||
14 | +132_s 131 | ||
15 | +136_s 135 | ||
16 | +137_s 136 | ||
17 | +148_s 147 | ||
18 | +188_s 186 | ||
19 | +196_s 194 | ||
20 | +216_s 214 | ||
21 | +219_s 217 | ||
22 | +226_s 224 | ||
23 | +227_s 225 | ||
24 | +229_s 227 | ||
25 | +230_s 228 | ||
26 | +234_s 232 | ||
27 | +238_s 236 | ||
28 | +244_s 242 | ||
29 | +245_s 243 | ||
30 | +269_s 266 | ||
31 | +275_s 272 | ||
32 | +281_s 278 | ||
33 | +287_s 284 | ||
34 | +290_s 287 | ||
35 | +301_s 297 | ||
36 | +302_s 298 | ||
37 | +303_s 299 | ||
38 | +315_s 311 | ||
39 | +332_s 328 | ||
40 | +350_s 346 | ||
41 | +361_s 357 | ||
42 | +366_s 362 | ||
43 | +379_s 375 | ||
44 | +415_s 411 | ||
45 | +421_s 417 | ||
46 | +444_s 440 | ||
47 | +445_s 441 | ||
48 | +446_s 442 | ||
49 | +453_s 449 | ||
50 | +#Cluster: 2 | ||
51 | +1_s 1 | ||
52 | +5_s 5 | ||
53 | +6_s 6 | ||
54 | +7_s 7 | ||
55 | +8_s 8 | ||
56 | +10_s 10 | ||
57 | +12_s 12 | ||
58 | +13_s 13 | ||
59 | +14_s 14 | ||
60 | +16_s 16 | ||
61 | +18_s 18 | ||
62 | +20_s 20 | ||
63 | +22_s 22 | ||
64 | +23_s 23 | ||
65 | +24_s 24 | ||
66 | +25_s 25 | ||
67 | +28_s 28 | ||
68 | +29_s 29 | ||
69 | +31_s 31 | ||
70 | +34_s 34 | ||
71 | +37_s 37 | ||
72 | +38_s 38 | ||
73 | +44_s 44 | ||
74 | +47_s 47 | ||
75 | +48_s 48 | ||
76 | +49_s 49 | ||
77 | +54_s 54 | ||
78 | +55_s 55 | ||
79 | +58_s 58 | ||
80 | +64_s 64 | ||
81 | +65_s 65 | ||
82 | +67_s 67 | ||
83 | +69_s 69 | ||
84 | +70_s 70 | ||
85 | +71_s 71 | ||
86 | +72_s 72 | ||
87 | +74_s 74 | ||
88 | +75_s 75 | ||
89 | +79_s 79 | ||
90 | +80_s 80 | ||
91 | +81_s 81 | ||
92 | +83_s 83 | ||
93 | +86_s 86 | ||
94 | +87_s 87 | ||
95 | +88_s 88 | ||
96 | +89_s 89 | ||
97 | +90_s 90 | ||
98 | +91_s 91 | ||
99 | +92_s 92 | ||
100 | +93_s 93 | ||
101 | +94_s 94 | ||
102 | +98_s 98 | ||
103 | +101_s 101 | ||
104 | +102_s 102 | ||
105 | +104_s 104 | ||
106 | +106_s 106 | ||
107 | +109_s 109 | ||
108 | +110_s 110 | ||
109 | +112_s 112 | ||
110 | +115_s 115 | ||
111 | +117_s 117 | ||
112 | +118_s 118 | ||
113 | +120_s 120 | ||
114 | +127_s 126 | ||
115 | +128_s 127 | ||
116 | +130_s 129 | ||
117 | +138_s 137 | ||
118 | +141_s 140 | ||
119 | +142_s 141 | ||
120 | +144_s 143 | ||
121 | +146_s 145 | ||
122 | +147_s 146 | ||
123 | +149_s 148 | ||
124 | +150_s 149 | ||
125 | +156_s 155 | ||
126 | +159_s 158 | ||
127 | +161_s 160 | ||
128 | +162_s 161 | ||
129 | +163_s 162 | ||
130 | +164_s 163 | ||
131 | +165_s 164 | ||
132 | +166_s 165 | ||
133 | +169_s 168 | ||
134 | +171_s 169 | ||
135 | +174_s 172 | ||
136 | +177_s 175 | ||
137 | +179_s 177 | ||
138 | +182_s 180 | ||
139 | +184_s 182 | ||
140 | +186_s 184 | ||
141 | +189_s 187 | ||
142 | +190_s 188 | ||
143 | +192_s 190 | ||
144 | +195_s 193 | ||
145 | +197_s 195 | ||
146 | +198_s 196 | ||
147 | +199_s 197 | ||
148 | +203_s 201 | ||
149 | +204_s 202 | ||
150 | +205_s 203 | ||
151 | +208_s 206 | ||
152 | +210_s 208 | ||
153 | +214_s 212 | ||
154 | +215_s 213 | ||
155 | +217_s 215 | ||
156 | +220_s 218 | ||
157 | +221_s 219 | ||
158 | +222_s 220 | ||
159 | +223_s 221 | ||
160 | +225_s 223 | ||
161 | +233_s 231 | ||
162 | +236_s 234 | ||
163 | +237_s 235 | ||
164 | +239_s 237 | ||
165 | +240_s 238 | ||
166 | +241_s 239 | ||
167 | +242_s 240 | ||
168 | +243_s 241 | ||
169 | +246_s 244 | ||
170 | +247_s 245 | ||
171 | +248_s 246 | ||
172 | +250_s 248 | ||
173 | +251_s 249 | ||
174 | +253_s 250 | ||
175 | +254_s 251 | ||
176 | +255_s 252 | ||
177 | +256_s 253 | ||
178 | +260_s 257 | ||
179 | +262_s 259 | ||
180 | +264_s 261 | ||
181 | +265_s 262 | ||
182 | +268_s 265 | ||
183 | +272_s 269 | ||
184 | +273_s 270 | ||
185 | +278_s 275 | ||
186 | +279_s 276 | ||
187 | +280_s 277 | ||
188 | +284_s 281 | ||
189 | +286_s 283 | ||
190 | +289_s 286 | ||
191 | +291_s 288 | ||
192 | +293_s 289 | ||
193 | +295_s 291 | ||
194 | +297_s 293 | ||
195 | +298_s 294 | ||
196 | +299_s 295 | ||
197 | +300_s 296 | ||
198 | +305_s 301 | ||
199 | +307_s 303 | ||
200 | +308_s 304 | ||
201 | +310_s 306 | ||
202 | +313_s 309 | ||
203 | +314_s 310 | ||
204 | +316_s 312 | ||
205 | +317_s 313 | ||
206 | +318_s 314 | ||
207 | +320_s 316 | ||
208 | +322_s 318 | ||
209 | +325_s 321 | ||
210 | +326_s 322 | ||
211 | +328_s 324 | ||
212 | +330_s 326 | ||
213 | +333_s 329 | ||
214 | +335_s 331 | ||
215 | +336_s 332 | ||
216 | +340_s 336 | ||
217 | +343_s 339 | ||
218 | +345_s 341 | ||
219 | +347_s 343 | ||
220 | +348_s 344 | ||
221 | +349_s 345 | ||
222 | +352_s 348 | ||
223 | +353_s 349 | ||
224 | +354_s 350 | ||
225 | +355_s 351 | ||
226 | +356_s 352 | ||
227 | +357_s 353 | ||
228 | +360_s 356 | ||
229 | +362_s 358 | ||
230 | +363_s 359 | ||
231 | +364_s 360 | ||
232 | +365_s 361 | ||
233 | +367_s 363 | ||
234 | +368_s 364 | ||
235 | +371_s 367 | ||
236 | +372_s 368 | ||
237 | +374_s 370 | ||
238 | +375_s 371 | ||
239 | +376_s 372 | ||
240 | +377_s 373 | ||
241 | +378_s 374 | ||
242 | +380_s 376 | ||
243 | +383_s 379 | ||
244 | +384_s 380 | ||
245 | +387_s 383 | ||
246 | +388_s 384 | ||
247 | +390_s 386 | ||
248 | +391_s 387 | ||
249 | +392_s 388 | ||
250 | +398_s 394 | ||
251 | +399_s 395 | ||
252 | +401_s 397 | ||
253 | +402_s 398 | ||
254 | +403_s 399 | ||
255 | +407_s 403 | ||
256 | +408_s 404 | ||
257 | +409_s 405 | ||
258 | +411_s 407 | ||
259 | +413_s 409 | ||
260 | +414_s 410 | ||
261 | +416_s 412 | ||
262 | +418_s 414 | ||
263 | +419_s 415 | ||
264 | +420_s 416 | ||
265 | +424_s 420 | ||
266 | +428_s 424 | ||
267 | +429_s 425 | ||
268 | +431_s 427 | ||
269 | +433_s 429 | ||
270 | +437_s 433 | ||
271 | +438_s 434 | ||
272 | +440_s 436 | ||
273 | +442_s 438 | ||
274 | +443_s 439 | ||
275 | +447_s 443 | ||
276 | +448_s 444 | ||
277 | +450_s 446 | ||
278 | +451_s 447 | ||
279 | +452_s 448 | ||
280 | +#Cluster: 3 | ||
281 | +9_s 9 | ||
282 | +19_s 19 | ||
283 | +21_s 21 | ||
284 | +26_s 26 | ||
285 | +32_s 32 | ||
286 | +39_s 39 | ||
287 | +52_s 52 | ||
288 | +73_s 73 | ||
289 | +77_s 77 | ||
290 | +95_s 95 | ||
291 | +107_s 107 | ||
292 | +113_s 113 | ||
293 | +125_s 125 | ||
294 | +129_s 128 | ||
295 | +131_s 130 | ||
296 | +145_s 144 | ||
297 | +153_s 152 | ||
298 | +158_s 157 | ||
299 | +172_s 170 | ||
300 | +175_s 173 | ||
301 | +180_s 178 | ||
302 | +200_s 198 | ||
303 | +202_s 200 | ||
304 | +207_s 205 | ||
305 | +224_s 222 | ||
306 | +228_s 226 | ||
307 | +231_s 229 | ||
308 | +259_s 256 | ||
309 | +263_s 260 | ||
310 | +274_s 271 | ||
311 | +283_s 280 | ||
312 | +288_s 285 | ||
313 | +306_s 302 | ||
314 | +321_s 317 | ||
315 | +323_s 319 | ||
316 | +334_s 330 | ||
317 | +359_s 355 | ||
318 | +382_s 378 | ||
319 | +395_s 391 | ||
320 | +417_s 413 | ||
321 | +434_s 430 | ||
322 | +454_s 450 | ||
323 | +#Cluster: 4 | ||
324 | +2_s 2 | ||
325 | +4_s 4 | ||
326 | +11_s 11 | ||
327 | +15_s 15 | ||
328 | +27_s 27 | ||
329 | +30_s 30 | ||
330 | +35_s 35 | ||
331 | +36_s 36 | ||
332 | +40_s 40 | ||
333 | +41_s 41 | ||
334 | +45_s 45 | ||
335 | +46_s 46 | ||
336 | +50_s 50 | ||
337 | +51_s 51 | ||
338 | +53_s 53 | ||
339 | +56_s 56 | ||
340 | +57_s 57 | ||
341 | +60_s 60 | ||
342 | +61_s 61 | ||
343 | +62_s 62 | ||
344 | +63_s 63 | ||
345 | +68_s 68 | ||
346 | +76_s 76 | ||
347 | +78_s 78 | ||
348 | +85_s 85 | ||
349 | +96_s 96 | ||
350 | +97_s 97 | ||
351 | +99_s 99 | ||
352 | +103_s 103 | ||
353 | +105_s 105 | ||
354 | +108_s 108 | ||
355 | +111_s 111 | ||
356 | +114_s 114 | ||
357 | +116_s 116 | ||
358 | +119_s 119 | ||
359 | +121_s 121 | ||
360 | +122_s 122 | ||
361 | +133_s 132 | ||
362 | +134_s 133 | ||
363 | +135_s 134 | ||
364 | +139_s 138 | ||
365 | +140_s 139 | ||
366 | +143_s 142 | ||
367 | +151_s 150 | ||
368 | +152_s 151 | ||
369 | +154_s 153 | ||
370 | +155_s 154 | ||
371 | +157_s 156 | ||
372 | +160_s 159 | ||
373 | +167_s 166 | ||
374 | +168_s 167 | ||
375 | +173_s 171 | ||
376 | +176_s 174 | ||
377 | +178_s 176 | ||
378 | +181_s 179 | ||
379 | +183_s 181 | ||
380 | +185_s 183 | ||
381 | +187_s 185 | ||
382 | +191_s 189 | ||
383 | +193_s 191 | ||
384 | +194_s 192 | ||
385 | +201_s 199 | ||
386 | +206_s 204 | ||
387 | +209_s 207 | ||
388 | +211_s 209 | ||
389 | +212_s 210 | ||
390 | +213_s 211 | ||
391 | +218_s 216 | ||
392 | +232_s 230 | ||
393 | +235_s 233 | ||
394 | +249_s 247 | ||
395 | +257_s 254 | ||
396 | +258_s 255 | ||
397 | +261_s 258 | ||
398 | +266_s 263 | ||
399 | +267_s 264 | ||
400 | +270_s 267 | ||
401 | +271_s 268 | ||
402 | +276_s 273 | ||
403 | +277_s 274 | ||
404 | +282_s 279 | ||
405 | +285_s 282 | ||
406 | +294_s 290 | ||
407 | +296_s 292 | ||
408 | +304_s 300 | ||
409 | +309_s 305 | ||
410 | +311_s 307 | ||
411 | +312_s 308 | ||
412 | +319_s 315 | ||
413 | +324_s 320 | ||
414 | +327_s 323 | ||
415 | +329_s 325 | ||
416 | +331_s 327 | ||
417 | +337_s 333 | ||
418 | +338_s 334 | ||
419 | +339_s 335 | ||
420 | +341_s 337 | ||
421 | +342_s 338 | ||
422 | +344_s 340 | ||
423 | +346_s 342 | ||
424 | +351_s 347 | ||
425 | +358_s 354 | ||
426 | +369_s 365 | ||
427 | +370_s 366 | ||
428 | +373_s 369 | ||
429 | +381_s 377 | ||
430 | +385_s 381 | ||
431 | +386_s 382 | ||
432 | +389_s 385 | ||
433 | +393_s 389 | ||
434 | +394_s 390 | ||
435 | +396_s 392 | ||
436 | +397_s 393 | ||
437 | +400_s 396 | ||
438 | +404_s 400 | ||
439 | +405_s 401 | ||
440 | +406_s 402 | ||
441 | +410_s 406 | ||
442 | +412_s 408 | ||
443 | +422_s 418 | ||
444 | +423_s 419 | ||
445 | +425_s 421 | ||
446 | +426_s 422 | ||
447 | +427_s 423 | ||
448 | +430_s 426 | ||
449 | +432_s 428 | ||
450 | +435_s 431 | ||
451 | +436_s 432 | ||
452 | +439_s 435 | ||
453 | +441_s 437 | ||
454 | +449_s 445 | ||
455 | +455_s 451 | ||
... | \ No newline at end of file | ... | \ No newline at end of file |
results/Partition_4/cluster1.txt
0 → 100644
1 | +Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis | ||
2 | +Upregulation of alveolar levels of activin B, but not activin A, in lungs of west highland white terriers with idiopathic pulmonary fibrosis and diffuse alveolar damage | ||
3 | +Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor | ||
4 | +Upregulation of activin-B and follistatin in pulmonary fibrosis - a translational study using human biopsies and a specific inhibitor in mouse fibrosis models | ||
5 | +Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration | ||
6 | +Interactions between b-catenin and transforming growth factor-b signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP) | ||
7 | +Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-b receptor I internalization and inhibiting transforming growth factor-b1 signaling | ||
8 | +Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia | ||
9 | +TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study | ||
10 | +Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis | ||
11 | +Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients | ||
12 | +The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo | ||
13 | +Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice | ||
14 | +Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression | ||
15 | +Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways | ||
16 | +Transforming growth factor-b1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway | ||
17 | +The anti-fibrotic effect of inhibition of TGFb-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent y-herpesvirus infection | ||
18 | +Transforming growth factor-b inhibits IQ motif containing guanosine triphosphatase activating protein 1 expression in lung fibroblasts via the nuclear factor-kB signaling pathway | ||
19 | +De-ubiquitinating enzyme, USP11, promotes transforming growth factor b-1 signaling through stabilization of transforming growth factor b receptor II | ||
20 | +Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor b receptor-dependent and -independent pathways | ||
21 | +Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition | ||
22 | +Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways | ||
23 | +Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis | ||
24 | +Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism | ||
25 | +Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation | ||
26 | +NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts | ||
27 | +Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-b1 and plasminogen activator inhibitor 1 | ||
28 | +Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis | ||
29 | +Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis | ||
30 | +Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta | ||
31 | +Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition | ||
32 | +Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-b1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis | ||
33 | +TGF-b1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts | ||
34 | +Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b | ||
35 | +Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis | ||
36 | +The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis | ||
37 | +Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis | ||
38 | +Are mast cells instrumental for fibrotic diseases? Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity | ||
39 | +The role of halofuginone in fibrosis: more to be explored? Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction in many inflammatory and metabolic diseases, including idiopathic pulmonary fibrosis (IPF), cirrhosis, nephropathy, and oral submucous fibrosis (OSF) | ||
40 | +CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis | ||
41 | +Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease with no known etiology and treatment options | ||
42 | +The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells | ||
43 | +PI3K p110y overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition | ||
44 | +Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase | ||
45 | +Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK | ||
46 | +Secreted protein acidic and rich in cysteine (SPARC) is upregulated by transforming growth factor (TGF)-b and is required for TGF-b-induced hydrogen peroxide production in fibroblasts | ||
47 | +Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-b1-induced pulmonary fibrosis | ||
48 | +Arsenic trioxide inhibits transforming growth factor-b1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo |
results/Partition_4/cluster1_tagged.txt
0 → 100644
1 | +Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through <g>ERK</g>/<g>Akt</g> <u>inhibition </u>and <g>PTEN</g> restoration | ||
2 | +Signaling pathways in the epithelial origins of <d>pulmonary fibrosis</d> | ||
3 | +Raised serum levels of <g>IGFBP-1</g> and <g>IGFBP-2</g> in <d>idiopathic pulmonary fibrosis</d> | ||
4 | +Methylation-mediated <g>BMPER</g> <e>expression </e>in fibroblast activation in vitro and lung <d>fibrosis</d> in mice in vivo | ||
5 | +<d>Fibrosis</d> of two: Epithelial cell-fibroblast interactions in <d>pulmonary fibrosis</d> | ||
6 | +Arsenic trioxide inhibits transforming growth factor-b1-induced <d>fibroblast to myofibroblast differentiation</d> in vitro and bleomycin induced lung <d>fibrosis</d> in vivo | ||
7 | +microRNA-1343 attenuates pathways of <d>fibrosis</d> by targeting the <g>TGF-b</g> receptors | ||
8 | +<g>Matrix metalloproteinase (MMP)-19</g> <u>deficient </u>fibroblasts display a profibrotic phenotype | ||
9 | +Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine <d>idiopathic pulmonary fibrosis</d> | ||
10 | +Genetic polymorphism in <g>matrix metalloproteinase-9</g> and <g>transforming growth factor-b1</g> and susceptibility to <d>combined pulmonary fibrosis</d> and <d>emphysema</d> in a Chinese population | ||
11 | +Transforming growth factor-b1 downregulates <g>vascular endothelial growth factor</g>-D expression in human lung fibroblasts via the <g>Jun NH2-terminal kinase</g> signaling pathway | ||
12 | +<g>Ubiquitin carboxyl-terminal hydrolase-L5</g> promotes <g>TGFb-1</g> signaling by de-ubiquitinating and stabilizing <g>Smad2</g>/<g>Smad3</g> in <d>pulmonary fibrosis</d> | ||
13 | +Effect of pirfenidone on proliferation, <g>TGF-b</g>-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts | ||
14 | +[Quantifying plasma levels of <g>transforming growth factor beta1</g> in <d>idiopathic pulmonary fibrosis</d>] | ||
15 | +The matricellular protein <g>CCN1</g> enhances <g>TGF-b1</g>/<g>SMAD3</g>-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to <d>lung injury</d> | ||
16 | +Bleomycin in the setting of <d>lung fibrosis</d> induction: From biological mechanisms to counteractions | ||
17 | +Alveolar epithelial cell injury with Epstein-Barr virus <v>upregulates </v><g>TGFbeta1</g> <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a refractory and lethal <d>interstitial lung disease</d> characterized by alveolar epithelial cells apoptosis, fibroblast proliferation, and ECM protein deposition | ||
18 | +Single-cell RNA sequencing identifies diverse roles of epithelial cells in <d>idiopathic pulmonary fibrosis</d> | ||
19 | +Data on <g>CUX1</g> isoforms in <d>idiopathic pulmonary fibrosis lung</d> and <d>systemic sclerosis</d> skin tissue sections | ||
20 | +<d>Idiopathic Pulmonary Fibrosis</d>: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics | ||
21 | +Genetic partitioning of <g>interleukin-6</g> signalling in mice dissociates <g>Stat3</g> from <g>Smad3</g>-mediated <d>lung fibrosis</d> | ||
22 | +Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in <d>idiopathic pulmonary fibrosis</d> | ||
23 | +Oxidant-antioxidant imbalance as a potential contributor to the progression of human <d>pulmonary fibrosis</d> | ||
24 | +Increased production and immunohistochemical localization of <g>transforming growth factor-beta</g> in <d>idiopathic pulmonary fibrosis</d> | ||
25 | +Type V collagen induced tolerance suppresses collagen deposition, <g>TGF-b</g> and associated transcripts in <d>pulmonary fibrosis</d> | ||
26 | +Preventive and therapeutic effects of thymosin b4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis | ||
27 | +FAK-related nonkinase is a multifunctional negative regulator of <d>pulmonary fibrosis</d> | ||
28 | +Nitrated fatty acids reverse <d>pulmonary fibrosis</d> by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages | ||
29 | +Cytokine profiles in <d>idiopathic pulmonary fibrosis</d> suggest an important role for <g>TGF-beta</g> and <g>IL-10</g> | ||
30 | +Sphingosine-1-phosphate is increased in patients with <d>idiopathic pulmonary fibrosis</d> and mediates epithelial to mesenchymal transition | ||
31 | +Leucine-rich a-2 glycoprotein promotes <d>lung fibrosis</d> by modulating <g>TGF-b</g> signaling in fibroblasts | ||
32 | +Sustained <g>PI3K</g> | ||
33 | +Pirfenidone <u>inhibits </u>the <e>expression </e>of <g>HSP47</g> in <g>TGF-beta1</g>-stimulated human lung fibroblasts | ||
34 | +Age-driven developmental drift in the pathogenesis of <d>idiopathic pulmonary fibrosis</d> | ||
35 | +Endogenous <g>Semaphorin-7A</g> | ||
36 | +Progressive transforming growth factor beta1-induced <d>lung fibrosis</d> is blocked by an orally active <g>ALK5</g> kinase <u>inhibitor.</u> <d>Pulmonary fibrosis</d> is characterized by chronic scar formation and deposition of extracellular matrix, resulting in <d>impaired lung function</d> and <d>respiratory failure</d> | ||
37 | +Compromised peroxisomes in <d>idiopathic pulmonary fibrosis</d>, a vicious cycle inducing a higher fibrotic response via <g>TGF-b</g> signaling | ||
38 | +Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced <d>pulmonary fibrosis</d> | ||
39 | +Intrinsic defence capacity and therapeutic potential of natriuretic peptides in <d>pulmonary hypertension</d> associated with <d>lung fibrosis</d> | ||
40 | +Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for <d>idiopathic pulmonary fibrosis</d> | ||
41 | +BAL cytokine profile in different <d>interstitial lung diseases</d>: a focus on <d>systemic sclerosis</d> | ||
42 | +Matrix metalloproteinase 3 is a mediator of <d>pulmonary fibrosis</d> | ||
43 | +<u>Inhibition </u>of <g>PHGDH</g> | ||
44 | +Bleomycin induces molecular changes directly relevant to <d>idiopathic pulmonary fibrosis</d>: a model for "active" disease | ||
45 | +Lysyl oxidases <r>regulate </r>fibrillar collagen remodelling in idiopathic pulmonary fibrosis | ||
46 | +Discovery and validation of extracellular/circulating microRNAs during <d>idiopathic pulmonary fibrosis disease</d> progression | ||
47 | +Recombinant human <g>serum amyloid P</g> in healthy volunteers and patients with <d>pulmonary fibrosis</d> | ||
48 | +<g>Transforming Growth Factor Beta 1</g> |
results/Partition_4/cluster2.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_4/cluster2_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_4/cluster3.txt
0 → 100644
1 | +Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema | ||
2 | +Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts | ||
3 | +Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis | ||
4 | +Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis | ||
5 | +The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis | ||
6 | +Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis | ||
7 | +Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs | ||
8 | +Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis | ||
9 | +Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis | ||
10 | +Amplification of TGFb Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis | ||
11 | +Macrophage Bone Morphogenic Protein Receptor 2 (BMPR2) depletion in Idiopathic Pulmonary Fibrosis (IPF) and Group III Pulmonary Hypertension | ||
12 | +Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion | ||
13 | +Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice | ||
14 | +Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis | ||
15 | +miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-b Receptor II | ||
16 | +Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2 | ||
17 | +Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-b1 Signal Pathway | ||
18 | +Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1 | ||
19 | +Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production | ||
20 | +Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen Production | ||
21 | +Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis | ||
22 | +Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2 | ||
23 | +Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model | ||
24 | +AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation | ||
25 | +Novel Mechanisms for the Antifibrotic Action of Nintedanib | ||
26 | +Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem | ||
27 | +Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia | ||
28 | +Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin avb6 Expression | ||
29 | +Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis | ||
30 | +The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis | ||
31 | +MAP3K19 Is a Novel Regulator of TGF-b Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis | ||
32 | +Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-b1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt | ||
33 | +Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts: Possible Implications in Idiopathic Pulmonary Fibrosis | ||
34 | +Regulation of 26S Proteasome Activity in Pulmonary Fibrosis | ||
35 | +Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis | ||
36 | +The Role of PPARs in Lung Fibrosis | ||
37 | +Lipoxin A4 Attenuates Constitutive and TGF-b1-Dependent Profibrotic Activity in Human Lung Myofibroblasts | ||
38 | +Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells | ||
39 | +Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics | ||
40 | +CXCL9 Regulates TGF-b1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells | ||
41 | +Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural Fibrosis | ||
42 | +Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-b and WNT7B in Human Lung Fibroblasts |
results/Partition_4/cluster3_tagged.txt
0 → 100644
1 | +<r>Regulation </r>of human lung fibroblast <g>C1q</g>-receptors by <g>transforming growth factor-beta</g> and <g>tumor necrosis factor-alpha</g> | ||
2 | +High levels of <g>IL-6</g> and <g>IL-8</g> characterize early-on <d>idiopathic pulmonary fibrosis</d> acute exacerbations | ||
3 | +Regulation of the effects of <g>TGF-beta 1</g> by activation of latent <g>TGF-beta 1</g> and differential <e>expression </e>of <g>TGF-beta receptors (T beta R-I and T beta R-II</g>) in <d>idiopathic pulmonary fibrosis</d> | ||
4 | +Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in <d>idiopathic pulmonary fibrosis</d> patients | ||
5 | +<g>miR-9-5p</g> suppresses pro-fibrogenic transformation of fibroblasts and prevents organ <d>fibrosis</d> by targeting <g>NOX4</g> and <g>TGFBR2</g> | ||
6 | +Profibrotic role of <g>WNT10A</g> via <g>TGF-b</g> signaling in <d>idiopathic pulmonary fibrosis</d> | ||
7 | +Microarray profiling reveals <u>suppressed </u>interferon stimulated gene program in fibroblasts from scleroderma-associated <d>interstitial lung disease</d> | ||
8 | +<g>IL-4</g> polymorphisms, HRCT score and lung tissue markers in <d>idiopathic pulmonary fibrosis</d> | ||
9 | +Herpes <d>virus infection</d> is associated with vascular remodeling and <d>pulmonary hypertension</d> in <d>idiopathic pulmonary fibrosis</d> | ||
10 | +Microencapsulation of lefty-secreting engineered cells for <d>pulmonary fibrosis</d> therapy in mice | ||
11 | +Targeting of <g>Discoidin Domain Receptor 2</g> (<g>DDR2</g>) Prevents Myofibroblast Activation and Neovessel Formation During <d>Pulmonary Fibrosis</d> | ||
12 | +Role of <g>protease-activated receptor-2</g> in <d>idiopathic pulmonary fibrosis</d> | ||
13 | +<g>Chop</g> | ||
14 | +<g>VCAM-1</g> is a <g>TGF-b1</g> inducible gene <v>upregulated </v>in <d>idiopathic pulmonary fibrosis</d> | ||
15 | +<u>Suppression </u>of <g>plasminogen activator inhibitor-1</g> by RNA interference attenuates <d>pulmonary fibrosis</d> | ||
16 | +<g>JAK2</g> mediates <d>lung fibrosis</d>, <d>pulmonary vascular remodelling</d> and <d>hypertension</d> in <d>idiopathic pulmonary fibrosis</d>: an experimental study | ||
17 | +Melatonin attenuates <g>TGFb1</g>-induced epithelial-mesenchymal transition in lung alveolar epithelial cells | ||
18 | +<r>Deregulation </r>of selective autophagy during aging and <d>pulmonary fibrosis</d>: the role of <g>TGFb1</g> | ||
19 | +<g>RhoA</g> signaling <r>modulates </r><g>cyclin D1</g> <e>expression </e>in human lung fibroblasts; implications for <d>idiopathic pulmonary fibrosis</d> | ||
20 | +Inhibitory effect of <g>receptor for advanced glycation end products</g> (<g>RAGE</g>) on the <g>TGF-b</g>-induced alveolar epithelial to mesenchymal transition | ||
21 | +<e>Effects </e>of the <d>tumor</d> suppressor <g>PTEN</g> on the pathogenesis of <d>idiopathic pulmonary fibrosis</d> in Chinese patients | ||
22 | +Triptolide suppresses paraquat induced <d>idiopathic pulmonary fibrosis</d> by inhibiting <g>TGFB1</g>-dependent epithelial mesenchymal transition | ||
23 | +<g>Endothelin-1</g> <v>induces </v>alveolar epithelial-mesenchymal transition through endothelin type A receptor-<v>mediated </v><e>production </e>of <g>TGF-beta1</g> | ||
24 | +<g>p63</g> - Key molecule in the early phase of <d>epithelial abnormality</d> in <d>idiopathic pulmonary fibrosis</d> | ||
25 | +The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in <d>idiopathic pulmonary fibrosis</d> | ||
26 | +<v>Upregulation </v>of <g>activin</g>-B and <g>follistatin</g> in <d>pulmonary fibrosis</d> - a translational study using human biopsies and a specific inhibitor in mouse <d>fibrosis</d> models | ||
27 | +<u>Inhibition </u>of the <g>KCa3.1</g> | ||
28 | +Current and novel drug therapies for <d>idiopathic pulmonary fibrosis</d> | ||
29 | +<g>Protease activated receptor-1</g> regulates macrophage-mediated cellular senescence: a risk for <d>idiopathic pulmonary fibrosis</d> | ||
30 | +Sphingolipids in <d>pulmonary fibrosis</d> | ||
31 | +Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts | ||
32 | +Pirfenidone for the treatment of <d>idiopathic pulmonary fibrosis</d> | ||
33 | +The anti-fibrotic effect of <u>inhibition </u>of <g>TGFb</g>-<g>ALK5</g> signalling in experimental <d>pulmonary fibrosis</d> in mice is attenuated in the presence of concurrent y-herpesvirus infection | ||
34 | +Angiotensin-<g>TGF-beta</g> 1 crosstalk in human <d>idiopathic pulmonary fibrosis</d>: autocrine mechanisms in myofibroblasts and macrophages | ||
35 | +SNAI transcription factors mediate epithelial-mesenchymal transition in <d>lung fibrosis</d> | ||
36 | +<g>MiR-338</g>* suppresses fibrotic pathogenesis in <d>pulmonary fibrosis</d> through targeting <g>LPA1</g> | ||
37 | +BALF N-acetylglucosaminidase and <g>beta-galactosidase</g> activities in <d>idiopathic pulmonary fibrosis</d> | ||
38 | +<g>Th1</g>/Th2 cytokine gene polymorphisms in patients with <d>idiopathic pulmonary fibrosis</d> | ||
39 | +Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen <e>Production.</e> <g>TGF-b</g> <v>promotes </v>excessive collagen deposition in <d>fibrotic diseases</d> such as <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>) | ||
40 | +The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells | ||
41 | +<g>Transcription factor GATA-6</g> is <e>expressed </e>in quiescent myofibroblasts in <d>idiopathic pulmonary fibrosis</d> | ||
42 | +Epithelial-to-mesenchymal transition and its role in <g>EGFR</g>-mutant <d>lung adenocarcinoma</d> and <d>idiopathic pulmonary fibrosis</d> |
results/Partition_4/cluster4.txt
0 → 100644
This diff is collapsed. Click to expand it.
results/Partition_4/cluster4_tagged.txt
0 → 100644
This diff is collapsed. Click to expand it.
-
Please register or login to post a comment